ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.

Sarah E Josefsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.